Mirati Therapeutics (MRTX) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Mirati Therapeutics Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
$257.91 million
Short Interest Ratio / Days to Cover
Last Record Date
December 31, 2023
Outstanding Shares
Percentage of Shares Shorted
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Mirati Therapeutics ?

Sign up to receive the latest short interest report for Mirati Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MRTX Short Interest Over Time

MRTX Days to Cover Over Time

MRTX Percentage of Float Shorted Over Time

Mirati Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/20234,390,000 shares $257.91 million -40.7%N/A2 $58.75
12/15/20237,400,000 shares $427.65 million +56.1%N/A3.3 $57.79
11/30/20234,740,000 shares $269.00 million -22.2%N/A2.1 $56.75
11/15/20236,090,000 shares $342.32 million +31.8%N/A2.7 $56.21
10/31/20234,620,000 shares $256.55 million -0.9%N/A2 $55.53
10/15/20234,660,000 shares $260.73 million -45.8%N/A2.1 $55.95
9/30/20238,590,000 shares $374.18 million -5.1%N/A4.4 $43.56
9/15/20239,050,000 shares $299.10 million -4.3%N/A7 $33.05
8/31/20239,460,000 shares $351.91 million -1.8%N/A8 $37.20
8/15/20239,630,000 shares $382.60 million +19.6%N/A7.7 $39.73
7/31/20238,050,000 shares $243.67 million -7.9%N/A6.9 $30.27
7/15/20238,740,000 shares $309.66 million +1.6%N/A8.5 $35.43
6/30/20238,600,000 shares $310.72 million +6.6%N/A8.3 $36.13
6/15/20238,070,000 shares $314.49 million +13.5%N/A7.7 $38.97
5/31/20237,110,000 shares $264.21 million +5.2%N/A6.8 $37.16
5/15/20236,760,000 shares $334.21 million -14.8%N/A6.9 $49.44
4/30/20237,930,000 shares $351.38 million -13.6%N/A7.9 $44.31
4/15/20239,180,000 shares $360.32 million -0.9%N/A8.6 $39.25
3/31/20239,260,000 shares $344.29 million +7.7%N/A8.3 $37.18
3/15/20238,600,000 shares $371.26 million -2.4%N/A6.8 $43.17
2/28/20238,810,000 shares $403.85 million -3.9%N/A5 $45.84
2/15/20239,170,000 shares $446.67 million -3.9%N/A4.9 $48.71
1/31/20239,540,000 shares $509.53 million -10.3%N/A4.9 $53.41
1/15/202310,630,000 shares $458.05 million +1.0%N/A5.7 $43.09
12/30/202210,530,000 shares $477.11 million +6.6%N/A5.9 $45.31
12/15/20229,880,000 shares $420.30 million +30.0%N/A5.9 $42.54
11/30/20227,600,000 shares $694.49 million -5.9%N/A5.8 $91.38
11/15/20228,080,000 shares $585.80 million +4.5%N/A8.4 $72.50
10/31/20227,730,000 shares $520.38 million -2.3%N/A10 $67.32
10/15/20227,910,000 shares $528.78 million +2.5%N/A9.4 $66.85
9/30/20227,720,000 shares $539.16 million -3.4%N/A8.4 $69.84
9/15/20227,990,000 shares $659.10 million +7.3%N/A8.1 $82.49
8/31/20227,450,000 shares $603.67 million -1.6%N/A6.7 $81.03
8/15/20227,570,000 shares $653.44 million +8.5%N/A4.8 $86.32
7/31/20226,980,000 shares $449.51 million -13.3%13.7%4.3 $64.40
7/15/20228,050,000 shares $483.16 million -2.2%24.0%5.2 $60.02
6/30/20228,230,000 shares $552.48 million +46.7%24.5%5.6 $67.13
6/15/20225,610,000 shares $302.66 million +19.1%16.7%4 $53.95
5/31/20224,710,000 shares $184.44 million -9.6%9.2%3.9 $39.16
5/15/20225,210,000 shares $296.14 million +24.1%10.2%7.1 $56.84
Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)

Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.

Click here for the full story…

MRTX Short Interest - Frequently Asked Questions

What is Mirati Therapeutics' current short interest?

Short interest is the volume of Mirati Therapeutics shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 4,390,000 shares of MRTX short. Learn More on Mirati Therapeutics' current short interest.

What is a good short interest ratio for Mirati Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRTX shares currently have a short interest ratio of 2.0. Learn More on Mirati Therapeutics's short interest ratio.

Which institutional investors are shorting Mirati Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mirati Therapeutics: Walleye Trading LLC, PEAK6 Investments LLC, and Equitec Proprietary Markets LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Mirati Therapeutics' short interest increasing or decreasing?

Mirati Therapeutics saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 4,390,000 shares, a decline of 40.7% from the previous total of 7,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Mirati Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Mirati Therapeutics: Perrigo Company plc (2.54%), Alkermes plc (7.62%), Crinetics Pharmaceuticals, Inc. (6.23%), Nuvalent, Inc. (20.08%), Insmed Incorporated (5.74%), Alpine Immune Sciences, Inc. (5.67%), Madrigal Pharmaceuticals, Inc. (18.68%), HUTCHMED (China) Limited (0.26%), Axsome Therapeutics, Inc. (16.23%), Prestige Consumer Healthcare Inc. (3.79%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: General Motors ($4.15 billion), T-Mobile US, Inc. ($3.92 billion), TC Energy Co. ($3.66 billion), Charter Communications, Inc. ($3.35 billion), Coinbase Global, Inc. ($3.32 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.80 billion), Rivian Automotive, Inc. ($2.44 billion), Moderna, Inc. ($2.41 billion), and United Rentals, Inc. ($2.23 billion). View all of the most shorted stocks.

What does it mean to sell short Mirati Therapeutics stock?

Short selling MRTX is an investing strategy that aims to generate trading profit from Mirati Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mirati Therapeutics?

A short squeeze for Mirati Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MRTX, which in turn drives the price of the stock up even further.

How often is Mirati Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRTX, twice per month. The most recent reporting period available is December, 31 2023.

More Short Interest Resources from MarketBeat

This page (NASDAQ:MRTX) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners